First patients dosed in ContraVir study comparing CMX157 and Viread - Healio
First patients dosed in ContraVir study comparing CMX157 and VireadHealioThis is the first study to directly compare lower doses of CMX157 to the standard daily dose of tenofovir DF (Viread, Gilead Sciences) in patients with hepatitis B.
Viread-Fälschung bei Axicorp - APOTHEKE ADHOC
APOTHEKE ADHOCViread-Fälschung bei AxicorpAPOTHEKE ADHOCBerlin - Der Reimporteur Axicorp ruft wegen Fälschungsverdachts zwei Chargen des HIV-Präparats Viread (Tenofovir) zurück.
Gilead greed protests continue at AIDS conference - FiercePharma
FiercePharmaGilead greed protests continue at AIDS conferenceFiercePharmaGilead wanted to keep prices high on fellow drug Viread until its patent was close to expiration, the suit claimed.
GSK expects deep discount for Viread in China to boost sales - FiercePharma
FiercePharmaGSK expects deep discount for Viread in China to boost salesFiercePharmaThere are a couple of ways to deal with government drug price cuts.
China Approves Use of GSK Vaccine Cervarix - Medscape
MedscapeChina Approves Use of GSK Vaccine CervarixMedscapeGSK has had a rough ride in China.